NUCLEIC ACIDS ENCODING A REGULATOR OF G PROTEIN SIGNALING, RGS18, AND USES THEREOF - Patent 1292616

(19)

(11)

EP 1 292 616 A2

(12)

(88)	Date of publication A3:
	19.09.2002

(43)	Date of publication:
	19.03.2003 Bulletin 2003/12

(21)	Application number: 01934909.1

(22)	Date of filing: 26.04.2001

(51)	International Patent Classification (IPC)⁷: C07K 14/47

(86)	International application number:
	PCT/US0113/540

(87)	International publication number:
	WO 0108/3514 (08.11.2001 Gazette 2001/45)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

28.04.2000 US 200786 P
02.08.2000 GB 0018833

(71)	Applicant: Aventis Pharmaceuticals Inc.
	Bridgewater, NJ 08807-0800 (US)

(72)	Inventors:
	MURRAY, David, L. Westerly, RI 02891 (US) GAGNON, Alison, W. Wayne, PA 19087 (US)

(74)	Representative: Müller-Gerger, Thomas
	Aventis Pharma Deutschland GmbHPatent- und LizenzabteilungIndustriepark Höchst/K801 65929 Frankfurt 65929 Frankfurt (DE)

(54)	NUCLEIC ACIDS ENCODING A REGULATOR OF G PROTEIN SIGNALING, RGS18, AND USES THEREOF